Investigating the effect of date palm pollen on menopausal symptoms in women affiliated by Comprehensive Health Services Centers in Rafsanjan ,2019

Determination the effect of palm pollen on menopausal symptoms of women covered by Rafsanjan Comprehensive Health Care Centers year 1398

A randomized controlled clinical trial with parallel groups, three blinded, randomized

The researcher, after approving the project in the Research Council of Rafsanjan University of Medical Sciences and obtaining the code of ethics and obtaining the necessary authorization to conduct research from the university, will refer to the midwifery units.Thus postmenopausal women are screened for entry requirements and if eligible, explaining the purpose of the study, they are invited to participate in the project and they will enter the study with written consent. Individuals will be assigned to the intervention and control groups randomly and It will be by lottery. The intervention group will be given 30 palm pollen capsules and the control group the same number of placebo capsules for one month, one capsule daily.The participants, the researcher, the data collector, and the statistical consultant are unaware of the type of medicine and the study will be three-blind.

Inclusion in the study: Age between 50 and 65 years At least 12 months or more since the last menstrual period Exclusion from the study: breast and uterine cancers, abnormal vaginal bleeding, depression or known mental disorders use of progestin hormone pills, contraceptive pills, agonists and gonadotropin releasing hormone antagonists, taking other herbal remedies regularly, liver, kidney and thyroid diseases

The intervention group received palm pollen capsules for 4 weeks at a daily dose of 300 mg and the control group received placebo capsules similar to the intervention capsules filled with starch for 4 weeks.

The status of menopausal symptoms with palm pollen capsules

The allocation to the intervention and control groups is random and will be by lottery. Put 55 sheets of code 1 and 55 of code 2 , in a container and stir. We ask each participant to remove one of the sheets from the container and randomly fall into one of the capsule consumption groups with code 1 or code 2.

Drug maker packs palm pollen and placebo capsules with codes 1 and 2 and is provided to postmenopausal women by a researcher or data collector.The questionnaires will be marked with codes 1 and 2, then the completed questionnaires are submitted to the statistical consultant for analysis.thus, the women participating in the project, the researcher, the data collector, and the statistical advisor of the type of drug will be unaware and the study will be three-blind.